Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ConsumerLab And Industry Trade Words Over GMP Testing Initiative

This article was originally published in The Tan Sheet

Executive Summary

ConsumerLab.com says criticism by dietary supplement industry experts and advocates is inaccurate and reflects their regard for the industry rather than consumers

You may also be interested in...



CRN Stands Up Against U.S. Sports Official's Criticism Of Supplement Quality

The supplement industry has been a frequent punching bag for athletes blaming tainted nutritionals for their performance-enhancing drug violations, but the Council for Responsible Nutrition is countering accusations by the head of the U.S. group that tests Olympic athletes

CRN Stands Up Against U.S. Sports Official's Criticism Of Supplement Quality

The supplement industry has been a frequent punching bag for athletes blaming tainted nutritionals for their performance-enhancing drug violations, but the Council for Responsible Nutrition is countering accusations by the head of the U.S. group that tests Olympic athletes

CRN Stands Up Against U.S. Sports Official's Criticism Of Supplement Quality

The supplement industry has been a frequent punching bag for athletes blaming tainted nutritionals for their performance-enhancing drug violations, but the Council for Responsible Nutrition is countering accusations by the head of the U.S. group that tests Olympic athletes

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel